Seminars in Hematology
Volume 43, Supplement 1 , Pages S33-S36, January 2006

Glanzmann’s Thrombasthenia Treatment: A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII and Other Hemostatic Agents

  • Man-Chiu Poon

      Affiliations

    • University of Calgary, Southern Alberta Hemophilia Clinic, Calgary Health Region, and Canadian Blood Services, Calgary, Canada.
    • Corresponding Author InformationAddress correspondence to Man-Chiu Poon, MD, University of Calgary, Foothills Hospital, 1403 29th Street NW, Calgary, Alberta, Canada T2N 2T9.
    • ,
  • Rainer Zotz

      Affiliations

    • Heinrich-Heine-Universität, Düsseldorf, Germany.
    • ,
  • Giovanni Di Minno

      Affiliations

    • Universita’ degli Studi di Napoli Federico II, IRCCS “Casa Sollievo della Sofferenza” S. Giovanni Rotondo, Italy.
    • ,
  • Zvika S. Abrams

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark.
    • ,
  • Jens B. Knudsen

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark.
    • ,
  • Yves Laurian

      Affiliations

    • AP-HP & UFR Medicine Paris XIII, Paris, France.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(05)00216-7

doi:10.1053/j.seminhematol.2005.11.009

Seminars in Hematology
Volume 43, Supplement 1 , Pages S33-S36, January 2006

Article Tools